Profound Medical Corp
TSX:PRN

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
TSX:PRN
Watchlist
Price: 11.32 CAD -0.88% Market Closed
Market Cap: 276.5m CAD
Have any thoughts about
Profound Medical Corp?
Write Note

Intrinsic Value

PRN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one PRN stock under the Base Case scenario is 6.2 CAD. Compared to the current market price of 11.32 CAD, Profound Medical Corp is Overvalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRN Intrinsic Value
6.2 CAD
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Profound Medical Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PRN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PRN?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Profound Medical Corp

Provide an overview of the primary business activities
of Profound Medical Corp.

What unique competitive advantages
does Profound Medical Corp hold over its rivals?

What risks and challenges
does Profound Medical Corp face in the near future?

Summarize the latest earnings call
of Profound Medical Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Profound Medical Corp.

Provide P/S
for Profound Medical Corp.

Provide P/E
for Profound Medical Corp.

Provide P/OCF
for Profound Medical Corp.

Provide P/FCFE
for Profound Medical Corp.

Provide P/B
for Profound Medical Corp.

Provide EV/S
for Profound Medical Corp.

Provide EV/GP
for Profound Medical Corp.

Provide EV/EBITDA
for Profound Medical Corp.

Provide EV/EBIT
for Profound Medical Corp.

Provide EV/OCF
for Profound Medical Corp.

Provide EV/FCFF
for Profound Medical Corp.

Provide EV/IC
for Profound Medical Corp.

Show me price targets
for Profound Medical Corp made by professional analysts.

What are the Revenue projections
for Profound Medical Corp?

How accurate were the past Revenue estimates
for Profound Medical Corp?

What are the Net Income projections
for Profound Medical Corp?

How accurate were the past Net Income estimates
for Profound Medical Corp?

What are the EPS projections
for Profound Medical Corp?

How accurate were the past EPS estimates
for Profound Medical Corp?

What are the EBIT projections
for Profound Medical Corp?

How accurate were the past EBIT estimates
for Profound Medical Corp?

Compare the revenue forecasts
for Profound Medical Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Profound Medical Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Profound Medical Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Profound Medical Corp compared to its peers.

Compare the P/E ratios
of Profound Medical Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Profound Medical Corp with its peers.

Analyze the financial leverage
of Profound Medical Corp compared to its main competitors.

Show all profitability ratios
for Profound Medical Corp.

Provide ROE
for Profound Medical Corp.

Provide ROA
for Profound Medical Corp.

Provide ROIC
for Profound Medical Corp.

Provide ROCE
for Profound Medical Corp.

Provide Gross Margin
for Profound Medical Corp.

Provide Operating Margin
for Profound Medical Corp.

Provide Net Margin
for Profound Medical Corp.

Provide FCF Margin
for Profound Medical Corp.

Show all solvency ratios
for Profound Medical Corp.

Provide D/E Ratio
for Profound Medical Corp.

Provide D/A Ratio
for Profound Medical Corp.

Provide Interest Coverage Ratio
for Profound Medical Corp.

Provide Altman Z-Score Ratio
for Profound Medical Corp.

Provide Quick Ratio
for Profound Medical Corp.

Provide Current Ratio
for Profound Medical Corp.

Provide Cash Ratio
for Profound Medical Corp.

What is the historical Revenue growth
over the last 5 years for Profound Medical Corp?

What is the historical Net Income growth
over the last 5 years for Profound Medical Corp?

What is the current Free Cash Flow
of Profound Medical Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Profound Medical Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Profound Medical Corp

Current Assets 48.5m
Cash & Short-Term Investments 34.1m
Receivables 7.2m
Other Current Assets 7.2m
Non-Current Assets 1.5m
PP&E 1.2m
Intangibles 374k
Current Liabilities 5.6m
Accounts Payable 2.7m
Other Current Liabilities 3m
Non-Current Liabilities 5.2m
Long-Term Debt 4.4m
Other Non-Current Liabilities 794k
Efficiency

Earnings Waterfall
Profound Medical Corp

Revenue
7.9m USD
Cost of Revenue
-3.1m USD
Gross Profit
4.8m USD
Operating Expenses
-35.5m USD
Operating Income
-30.7m USD
Other Expenses
3.1m USD
Net Income
-27.6m USD

Free Cash Flow Analysis
Profound Medical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PRN Profitability Score
Profitability Due Diligence

Profound Medical Corp's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Positive 1-Year Revenue Growth
Negative 3-Years Revenue Growth
23/100
Profitability
Score

Profound Medical Corp's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

PRN Solvency Score
Solvency Due Diligence

Profound Medical Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Profound Medical Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRN Price Targets Summary
Profound Medical Corp

Wall Street analysts forecast PRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRN is 16.38 CAD with a low forecast of 14.26 CAD and a high forecast of 18.9 CAD.

Lowest
Price Target
14.26 CAD
26% Upside
Average
Price Target
16.38 CAD
45% Upside
Highest
Price Target
18.9 CAD
67% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PRN?

Click here to dive deeper.

Dividends

Profound Medical Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for PRN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Profound Medical Corp Logo
Profound Medical Corp

Country

Canada

Industry

Health Care

Market Cap

277.1m CAD

Dividend Yield

0%

Description

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Contact

ONTARIO
Mississauga
2400 Skymark Ave Unit 6
+16474761350.0
www.profoundmedical.com

IPO

2014-09-24

Employees

146

Officers

Chairman of the Board & CEO
Dr. Arun Swarup Menawat MBA, Ph.D.
Chief Financial Officer
Mr. Rashed Dewan
Chief Operating Officer
Dr. Mathieu Burtnyk
Investor Relations
Mr. Stephen Kilmer
Chief Commercial Officer
Mr. Thomas Tamberrino MBA
Assistant Corporate Controller
Mr. Matthew Sobczyk C.A., CPA
Show More
Software Developer
Mr. Levant Tinaz
Show Less

See Also

Discover More
What is the Intrinsic Value of one PRN stock?

The intrinsic value of one PRN stock under the Base Case scenario is 6.2 CAD.

Is PRN stock undervalued or overvalued?

Compared to the current market price of 11.32 CAD, Profound Medical Corp is Overvalued by 45%.

Back to Top